Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does APREPITANT Cause Obesity? 235 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 235 reports of Obesity have been filed in association with APREPITANT (CINVANTI). This represents 4.2% of all adverse event reports for APREPITANT.

235
Reports of Obesity with APREPITANT
4.2%
of all APREPITANT reports
205
Deaths
233
Hospitalizations

How Dangerous Is Obesity From APREPITANT?

Of the 235 reports, 205 (87.2%) resulted in death, 233 (99.1%) required hospitalization, and 231 (98.3%) were considered life-threatening.

Is Obesity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 235 reports have been filed with the FAERS database.

What Other Side Effects Does APREPITANT Cause?

Fatigue (955) Pyrexia (913) Dyspnoea (909) Hypersensitivity (881) Rash (789) Alopecia (760) Gastrointestinal disorder (722) Pruritus (707) Confusional state (696) Glossodynia (696)

What Other Drugs Cause Obesity?

RISPERIDONE (3,039) PREDNISONE (1,880) METHOTREXATE (1,876) ADALIMUMAB (1,780) TOCILIZUMAB (1,630) ABATACEPT (1,605) INFLIXIMAB (1,536) HYDROXYCHLOROQUINE (1,532) SULFASALAZINE (1,455) ETANERCEPT (1,407)

Which APREPITANT Alternatives Have Lower Obesity Risk?

APREPITANT vs APROTININ APREPITANT vs ARANESP APREPITANT vs ARAVA APREPITANT vs AREDIA APREPITANT vs ARFORMOTEROL

Related Pages

APREPITANT Full Profile All Obesity Reports All Drugs Causing Obesity APREPITANT Demographics